Nanoparticle formulations of siRNA: The next generation of targeted therapy for lymphomas and leukemias?

Andrew Z. Wang

doi:10.1016/j.ebiom.2014.11.013

Nanoparticle formulations of siRNA: The next generation of targeted therapy for lymphomas and leukemias?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	101-102
Number of pages	2
Journal	EBioMedicine
Volume	1
Issue number	2-3
DOIs	https://doi.org/10.1016/j.ebiom.2014.11.013
State	Published - 2014
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/j.ebiom.2014.11.013

Cite this

@article{78509db4a56343358221d0e398e6422d,

title = "Nanoparticle formulations of siRNA: The next generation of targeted therapy for lymphomas and leukemias?",

author = "Wang, {Andrew Z.}",

note = "Funding Information: AZW is supported by R01CA178748-01 from the National Institutes of Health/National Cancer Institute and 1-U54-CA151652-01 from the National Institutes of Health Center for Nanotechnology Excellence . The author declared no conflicts of interest.",

year = "2014",

doi = "10.1016/j.ebiom.2014.11.013",

language = "English (US)",

volume = "1",

pages = "101--102",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

number = "2-3",

}

TY - JOUR

T1 - Nanoparticle formulations of siRNA

T2 - The next generation of targeted therapy for lymphomas and leukemias?

AU - Wang, Andrew Z.

N1 - Funding Information: AZW is supported by R01CA178748-01 from the National Institutes of Health/National Cancer Institute and 1-U54-CA151652-01 from the National Institutes of Health Center for Nanotechnology Excellence . The author declared no conflicts of interest.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84922024175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922024175&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2014.11.013

DO - 10.1016/j.ebiom.2014.11.013

M3 - Comment/debate

C2 - 26137516

AN - SCOPUS:84922024175

SN - 2352-3964

VL - 1

SP - 101

EP - 102

JO - EBioMedicine

JF - EBioMedicine

IS - 2-3

ER -

Nanoparticle formulations of siRNA: The next generation of targeted therapy for lymphomas and leukemias?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this